APR 15·StreetInsider▼
QuidelOrtho reports preliminary Q1 2026 revenue of $615-620 million
QuidelOrtho (NASDAQ: QDEL) announced preliminary unaudited revenue of $615-620 million for the first quarter of 2026, a figure impacted by a weaker respiratory season and slower international sales. Despite these macroeconomic challenges, the company's CEO, Brian J. Blaser, stated that the core business remains strong, and QuidelOrtho is taking cost actions to drive full-year performance. The company expects negative free cash flow for Q1 and H1 2026 but maintains its full-year positive free cash flow outlook.
APR 15·Stock Titan▼
Weaker flu season weighs on QuidelOrtho as Q1 sales fall below $620M
QuidelOrtho announced preliminary unaudited Q1 2026 revenue of $615-$620 million, attributing the lower figures to a weaker respiratory season, slower China distributor sales, and delayed EMEA orders due to ongoing conflicts. Despite an expected negative free cash flow for Q1 2026, the company maintains that the low end of its full-year 2026 financial guidance is still achievable. Full financial results for Q1 2026 are scheduled for release on May 5, 2026.
